The Department of Surgery doesn’t just excel in the operating room. Through our extensive and innovative research programs, we are also focused on the development of new techniques and therapies that promote better outcomes and improve the quality of life for patients following surgery.
As part of that goal, the department’s surgeons are involved in groundbreaking clinical trials. In addition to their research value, clinical trials may also give patients access to new treatments that are not available anywhere else.
Learn more about our current clinical trials below or visit the Joint Clinical Trials Office at Weill Cornell Medicine and NewYork-Presbyterian.
Catheter ablation has emerged as an effective therapy for patients with atrial fibrillation (AF) in whom medications are not effective. The pulmonary veins (PVs) are the most common source of triggers of AF. Hence, the central approach in catheter ablation of atrial fibrillation involves creating
- All patients undergoing catheter ablation of atrial fibrillation
- Between the ages of 18 and 85
- More detailed eligibility discussed when you contact the study team